Vasbinder Erwin C, Belitser Svetlana V, Souverein Patrick C, van Dijk Liset, Vulto Arnold G, van den Bemt Patricia Mla
Erasmus University Medical Center, Department of Hospital Pharmacy, Rotterdam, the Netherlands.
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands.
Patient Prefer Adherence. 2016 Apr 12;10:531-8. doi: 10.2147/PPA.S92824. eCollection 2016.
Non-adherence to inhaled corticosteroids (ICSs) is a major risk factor for poor asthma control in children. However, little is known about the effect of adherence to ICS on the incidence of asthma exacerbations. The objective of this study was to examine the effect of poor adherence to ICS on the risk of exacerbations in children with asthma.
In this nested case-control study using data from the Dutch PHARMO Record Linkage System, children aged 5-12 years who had an asthma exacerbation needing oral corticosteroids or hospital admission were matched to patients without exacerbations. Refill adherence was calculated as medication possession ratio from ICS-dispensing records. Data were analyzed using a multivariable multiplicative intensity regression model.
A total of 646 children were included, of whom 36 had one or more asthma exacerbations. The medication possession ratio was 67.9% (standard deviation [SD] 30.2%) in children with an exacerbation versus 54.2% (SD 35.6%) in the control group. In children using long-acting beta-agonist, good adherence to ICS was associated with a higher risk of asthma exacerbations: relative risk 4.34 (95% confidence interval: 1.20-15.64).
In children with persistent asthma needing long-acting beta-agonist, good adherence to ICS was associated with an increased risk of asthma exacerbations. Possible explanations include better motivation for adherence to ICS in children with more severe asthma, and reduced susceptibility to the consequences of non-adherence to ICS due to overprescription of ICS to children who are in clinical remission. Further study into the background of the complex interaction between asthma and medication adherence is needed.
不坚持使用吸入性糖皮质激素(ICS)是儿童哮喘控制不佳的主要风险因素。然而,关于坚持使用ICS对哮喘急性发作发生率的影响知之甚少。本研究的目的是探讨不坚持使用ICS对哮喘儿童急性发作风险的影响。
在这项嵌套病例对照研究中,使用荷兰PHARMO记录链接系统的数据,将5至12岁因哮喘急性发作需要口服糖皮质激素或住院治疗的儿童与未发生急性发作的患者进行匹配。根据ICS配药记录计算再填充依从性,以药物持有率表示。使用多变量乘法强度回归模型分析数据。
共纳入646名儿童,其中36名有一次或多次哮喘急性发作。急性发作儿童的药物持有率为67.9%(标准差[SD]30.2%),而对照组为54.2%(SD 35.6%)。在使用长效β受体激动剂的儿童中,良好的ICS依从性与较高的哮喘急性发作风险相关:相对风险为4.34(95%置信区间:1.20 - 15.64)。
在需要长效β受体激动剂的持续性哮喘儿童中,良好的ICS依从性与哮喘急性发作风险增加相关。可能的解释包括病情较重的儿童坚持使用ICS的动机更强,以及由于对临床缓解期儿童过度开具ICS处方,导致对不坚持使用ICS后果的易感性降低。需要进一步研究哮喘与药物依从性之间复杂相互作用的背景。